11/21
08:00 am
plrx
Pliant Therapeutics to Participate in Upcoming Investor Events
Low
Report
Pliant Therapeutics to Participate in Upcoming Investor Events
11/18
06:00 pm
plrx
Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting® 2024
Medium
Report
Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting® 2024
11/8
12:31 pm
plrx
Pliant Therapeutics, Inc. (NASDAQ: PLRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
Medium
Report
Pliant Therapeutics, Inc. (NASDAQ: PLRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
11/7
04:18 pm
plrx
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
Low
Report
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
11/7
04:05 pm
plrx
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
Low
Report
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
11/6
08:00 am
plrx
Pliant Therapeutics to Participate in the Stifel Healthcare Conference
Medium
Report
Pliant Therapeutics to Participate in the Stifel Healthcare Conference
10/17
08:00 am
plrx
Pliant Therapeutics INTEGRIS-PSC Phase 2a Data Evaluating Bexotegrast in Primary Sclerosing Cholangitis to be Highlighted in a Late-Breaking Presentation at The Liver Meeting® 2024
Low
Report
Pliant Therapeutics INTEGRIS-PSC Phase 2a Data Evaluating Bexotegrast in Primary Sclerosing Cholangitis to be Highlighted in a Late-Breaking Presentation at The Liver Meeting® 2024
10/1
04:35 pm
plrx
Pliant Therapeutics Appoints Gary Palmer, M.D. as Senior Vice President of Medical Affairs
Medium
Report
Pliant Therapeutics Appoints Gary Palmer, M.D. as Senior Vice President of Medical Affairs
9/30
04:45 pm
plrx
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
High
Report
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
9/13
08:02 am
plrx
Pliant Therapeutics, Inc. (NASDAQ: PLRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
Medium
Report
Pliant Therapeutics, Inc. (NASDAQ: PLRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
9/13
05:59 am
plrx
PF Awareness Month emphasises the importance of early diagnosis [Yahoo! Finance]
Medium
Report
PF Awareness Month emphasises the importance of early diagnosis [Yahoo! Finance]
9/11
07:53 pm
plrx
Pliant Therapeutics: Good Data, But Will Need Watching [Seeking Alpha]
Medium
Report
Pliant Therapeutics: Good Data, But Will Need Watching [Seeking Alpha]
9/10
08:00 am
plrx
Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Respiratory Society International Congress 2024
Low
Report
Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Respiratory Society International Congress 2024
9/10
05:56 am
plrx
Pliant Therapeutics, Inc. (NASDAQ: PLRX) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Low
Report
Pliant Therapeutics, Inc. (NASDAQ: PLRX) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
9/9
09:01 am
plrx
Pliant Therapeutics, Inc. (NASDAQ: PLRX) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $33.00 price target on the stock.
Low
Report
Pliant Therapeutics, Inc. (NASDAQ: PLRX) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $33.00 price target on the stock.
8/28
08:00 am
plrx
Pliant Therapeutics to Participate in Upcoming Investor Events
Low
Report
Pliant Therapeutics to Participate in Upcoming Investor Events
8/26
09:15 am
plrx
Pliant Therapeutics Announces Four Upcoming Presentations at the European Respiratory Society International Congress 2024 [Yahoo! Finance]
Neutral
Report
Pliant Therapeutics Announces Four Upcoming Presentations at the European Respiratory Society International Congress 2024 [Yahoo! Finance]
8/26
09:10 am
plrx
Pliant Therapeutics Announces Four Upcoming Presentations at the European Respiratory Society International Congress 2024
Neutral
Report
Pliant Therapeutics Announces Four Upcoming Presentations at the European Respiratory Society International Congress 2024